Yoshiaki Hirayama Selected Research

Low Density Lipoprotein Receptor-Related Protein-2

5/2024	Megalin-related mechanism of hemolysis-induced acute kidney injury and the therapeutic strategy.
8/2022	Correction: Urinary C-megalin for screening of renal scarring in children after febrile urinary tract infection.
12/2019	Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
1/2018	Urinary Iron Excretion is Associated with Urinary Full-Length Megalin and Renal Oxidative Stress in Chronic Kidney Disease.
1/2018	Urinary C-megalin for screening of renal scarring in children after febrile urinary tract infection.
1/2017	Exocytosis-Mediated Urinary Full-Length Megalin Excretion Is Linked With the Pathogenesis of Diabetic Nephropathy.
1/2017	Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.
1/2014	Significance of urinary full-length megalin in patients with IgA nephropathy.
5/2012	Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiaki Hirayama Research Topics

Disease

3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017 - 05/2012
3	Type 2 Diabetes Mellitus (MODY) 01/2017 - 05/2012
2	Proteinuria 11/2022 - 01/2017
2	Urinary Tract Infections (Urinary Tract Infection) 08/2022 - 01/2018
2	Cicatrix (Scar) 08/2022 - 01/2018
2	Wilms Tumor (Wilm's Tumor) 05/2015 - 06/2012
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2014 - 09/2012
1	Acute Kidney Injury (Acute Renal Failure) 05/2024
1	Hemolysis 05/2024
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 05/2024
1	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2022
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2022
1	Hypoxia (Hypoxemia) 10/2020
1	Microaneurysm 10/2020
1	Neoplasms (Cancer) 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2019
1	Malignant Mesothelioma 12/2019
1	Atherosclerosis 10/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2018
1	Chronic Renal Insufficiency 01/2018
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 01/2017
1	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2016
1	Fabry Disease (Fabry's Disease) 05/2015
1	Disease Progression 01/2014
1	Sclerosis 09/2012
1	Hemorrhage 05/2012
1	Albuminuria 05/2012
1	Anemia 05/2012

Drug/Important Bio-Agent (IBA)

9	Low Density Lipoprotein Receptor-Related Protein-2IBA 05/2024 - 05/2012
6	podocalyxinIBA 10/2020 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 12/2019 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 09/2012
2	Hemoglobins (Hemoglobin)IBA 05/2024 - 05/2012
2	AlbuminsIBA 10/2020 - 05/2012
2	CreatinineIBA 01/2018 - 09/2012
2	VimentinIBA 05/2015 - 06/2012
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 05/2024
1	Heme (Haem)IBA 05/2024
1	HemopexinIBA 05/2024
1	LigandsIBA 05/2024
1	Cilastatin FDA Link 05/2024
1	Immunoglobulin G (IgG)IBA 11/2022
1	AutoantibodiesIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	IronIBA 01/2018
1	Inositol (Myoinositol)IBA 01/2017
1	GalactosidasesIBA 05/2015
1	AntibodiesIBA 05/2015
1	globotriaosylceramide (globotriosylceramide)IBA 05/2015
1	nephrinIBA 06/2012
1	Phosphates (Orthophosphate)IBA 05/2012
1	ImmunosorbentsIBA 05/2012
1	EnzymesIBA 05/2012
1	HematinicsIBA 05/2012
1	Monoclonal AntibodiesIBA 05/2012
1	Vitamin D FDA LinkGeneric 05/2012

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 12/2019